Townson Sharon bought GLUE
May 29, 2026 · Form 4 insider transaction
Townson Sharon bought 6,000 shares of Monte Rosa Therapeutics, Inc. at $6.14 per share, a transaction worth $36.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$6.14
Total value
$36.8K
InsiderTownson Sharon
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 29, 2026
Filing dateJune 1, 2026
Shares owned after73,845
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.